Skip to main content
TipRanks
Go Ultimate75% OFF

CANbridge Pharmaceuticals Inc. (1228) Financial Statements

0 Followers

CANbridge Pharmaceuticals Inc. Financial Overview

CANbridge Pharmaceuticals Inc.'s market cap is currently ¥1.02B. The company's EPS TTM is ¥-0.16; its P/E ratio is -9.02; CANbridge Pharmaceuticals Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 49.98M¥ 85.10M¥ 102.87M¥ 78.97M¥ 31.16M
Gross Profit¥ 36.55M¥ 54.30M¥ 64.16M¥ 48.89M¥ 18.78M
Operating Income¥ -92.70M¥ -340.51M¥ -366.55M¥ -457.97M¥ -655.15M
EBITDA¥ -80.55M¥ -313.26M¥ -341.43M¥ -454.63M¥ -1.06B
Net Income¥ 14.82M¥ -442.62M¥ -378.84M¥ -483.48M¥ -1.08B
Balance Sheet
Cash & Short-Term Investments¥ 66.65M¥ 10.50M¥ 137.49M¥ 451.16M¥ 745.82M
Total Assets¥ 165.46M¥ 116.81M¥ 395.36M¥ 702.04M¥ 892.52M
Total Debt¥ 16.09M¥ 135.78M¥ 141.93M¥ 155.28M¥ 52.10M
Net Debt¥ -50.56M¥ 125.28M¥ 17.03M¥ -295.88M¥ -693.71M
Total Liabilities¥ 507.36M¥ 591.30M¥ 435.15M¥ 393.49M¥ 199.13M
Stockholders' Equity¥ -341.90M¥ -474.49M¥ -39.79M¥ 308.56M¥ 693.39M
Cash Flow
Free Cash Flow¥ -38.22M¥ -122.50M¥ -319.09M¥ -315.76M¥ -592.40M
Operating Cash Flow¥ -38.21M¥ -122.39M¥ -278.23M¥ -280.98M¥ -587.07M
Investing Cash Flow¥ 1.23M¥ 13.93M¥ -26.86M¥ -34.79M¥ 126.09M
Financing Cash Flow¥ 92.47M¥ -18.57M¥ -28.02M¥ -20.70M¥ 854.31M

Currency in CNY

CANbridge Pharmaceuticals Inc. Earnings and Revenue History

-1.2B-600M0600M-16000 %-8000 %0 %8000 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin

CANbridge Pharmaceuticals Inc. Liabilities to Assets

01B2B3B0 %500 %1000 %1500 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

CANbridge Pharmaceuticals Inc. Cash Flow

-750M-500M-250M0250M500M750M1B2019202020212022202320242025OperatingInvestingFinancing

CANbridge Pharmaceuticals Inc. Forecast EPS vs Actual EPS

-1-0.7-0.5-0.200.30.5Q2 24Q4 24Q2 25Q4 25Q2 26Q4 26EPS EstimateBeatMiss